Vaccines as Technology: Innovation, Barriers, and the Public Health
Autor Ana Santos Rutschmanen Limba Engleză Paperback – 13 apr 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 280.53 lei 6-8 săpt. | |
Cambridge University Press – 13 apr 2022 | 280.53 lei 6-8 săpt. | |
Hardback (1) | 495.89 lei 6-8 săpt. | |
Cambridge University Press – 13 apr 2022 | 495.89 lei 6-8 săpt. |
Preț: 280.53 lei
Nou
Puncte Express: 421
Preț estimativ în valută:
53.69€ • 55.84$ • 44.32£
53.69€ • 55.84$ • 44.32£
Carte tipărită la comandă
Livrare economică 14-28 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781009125765
ISBN-10: 1009125761
Pagini: 250
Dimensiuni: 151 x 229 x 12 mm
Greutate: 0.28 kg
Ediția:Nouă
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
ISBN-10: 1009125761
Pagini: 250
Dimensiuni: 151 x 229 x 12 mm
Greutate: 0.28 kg
Ediția:Nouă
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
Cuprins
Introduction; 1. Vaccines as instruments of public health; 2. The vaccine development ecosystem; 3. Vaccine development under proprietary paradigms; 4. Access to vaccine technology; 5. Aligning vaccine innovation with public health needs; 6. Vaccines of the future: present and emerging challenges; Conclusion: broader implications for global public health.
Recenzii
'Vaccines as Technology - a timely book demonstrating that the battles over COVID vaccine nationalism and equity are not new but are rooted in the legal structure surrounding how vaccines are created, licensed, and sold. The book explores both the well-worn battle ground of intellectual property rights, but also focuses on the power of contract law to either extend or withhold equity in global vaccine distribution. Essential reading for anyone wanting to understand the broader legal and historical contexts behind the problems we face with COVID vaccine distribution.' Kevin Outterson, Professor of Law and N. Neal Pike Scholar in Health and Disability Law, Boston University School of Law and Executive Director of CARB-X
'This important book could not have come at a better time; it will be an invaluable resource for anyone interested in public health, innovation, and preparedness for emerging pathogens.' Lindsay Wiley, Professor of Law, UCLA Law
'Although vaccines prevent more deaths and misery than any other biomedical intervention, as a pharmaceutical product they are uniquely difficult to develop, produce and distribute. To protect the public health, vaccines must be inexpensive enough to protect billions yet efficient enough to be administered only a few times in a lifetime, rendering them less appealing to investors than expensive treatments for chronic illness. In addition, vaccines are difficult to make safely and are a hard sell to healthy people in the face of growing disinformation. Ana Santos Rutschman provides an extremely helpful, comprehensive and timely explanation of these paradoxical challenges, updated with the story of the Covid-19 vaccines and suggestions for paths toward more stability in the vaccine enterprise.' Arthur Allen, Reporter and Editor, Kaiser Health News, Author, Vaccine: the controversial story of medicine's greatest lifesaver (WW Norton); The Fantastic Laboratory of Dr. Weigl (WW Norton)
'This important book could not have come at a better time; it will be an invaluable resource for anyone interested in public health, innovation, and preparedness for emerging pathogens.' Lindsay Wiley, Professor of Law, UCLA Law
'Although vaccines prevent more deaths and misery than any other biomedical intervention, as a pharmaceutical product they are uniquely difficult to develop, produce and distribute. To protect the public health, vaccines must be inexpensive enough to protect billions yet efficient enough to be administered only a few times in a lifetime, rendering them less appealing to investors than expensive treatments for chronic illness. In addition, vaccines are difficult to make safely and are a hard sell to healthy people in the face of growing disinformation. Ana Santos Rutschman provides an extremely helpful, comprehensive and timely explanation of these paradoxical challenges, updated with the story of the Covid-19 vaccines and suggestions for paths toward more stability in the vaccine enterprise.' Arthur Allen, Reporter and Editor, Kaiser Health News, Author, Vaccine: the controversial story of medicine's greatest lifesaver (WW Norton); The Fantastic Laboratory of Dr. Weigl (WW Norton)
Notă biografică
Descriere
Examines the development and allocation of vaccines against emerging diseases from the viewpoint of technology and innovation policy.